Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

Functional training: Functional training goes well with yoga as it includes agile movements, compound movements, bouncing, ...

Eggs are probably top of mind when you think about adding more protein to your breakfast, but don’t forget about plant-based ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

For those looking to attain a healthy body weight in 2025, there are a few options to consider. Dr. Will Cauthen, a ...

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Sofia Alessia, 27, suffered severe complications and has warned others that, ‘weight loss surgery isn't worth the pain’. A ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes. View on euronews ...

Combining time-restricted eating with exercise may be more effective in prompting weight loss than exercise without ...